An open-label phase II trial of G-FLIP (low doses of gemcitabine, 5-FU, leucovorin, irinotecan & oxaliplatin), followed by G-FLIP-DM (G-FLIP + low doses of docetaxel & mitomycin C), used concurrently with ascorbic acid (AA), in patients with advanced pancreatic cancer.

2016 ◽  
Vol 34 (15_suppl) ◽  
pp. e15745-e15745
Author(s):  
Azriel Hirschfeld ◽  
Howard Bruckner
Cancer ◽  
1978 ◽  
Vol 41 (2) ◽  
pp. 387-391 ◽  
Author(s):  
R. Glen Wiggans ◽  
Paul V. Woolley ◽  
John S. Macdonald ◽  
Tarilyn Smythe ◽  
Winston Ueno ◽  
...  

2016 ◽  
Vol 115 (9) ◽  
pp. e16-e16 ◽  
Author(s):  
Angus G Dalgleish ◽  
Justin Stebbing ◽  
Douglas J A Adamson ◽  
Seema Safia Arif ◽  
Paolo Bidoli ◽  
...  

2014 ◽  
Vol 50 (18) ◽  
pp. 3136-3144 ◽  
Author(s):  
Tamas Hickish ◽  
Jim Cassidy ◽  
David Propper ◽  
Ian Chau ◽  
Stephen Falk ◽  
...  

2019 ◽  
Vol 10 (25) ◽  
pp. 6185-6190
Author(s):  
Seung Tae Kim ◽  
Sung Yong Oh ◽  
Jeeyun Lee ◽  
Jung Hun Kang ◽  
Hyun Woo Lee ◽  
...  

Sign in / Sign up

Export Citation Format

Share Document